SOLARA ACTIVE PHARMA SCIENCES LIMITED — Major Shareholding Notification 2022

Nov 30, 2022

Regd. Office: Plot No. 30, 'Galaxy', 1st Main Road, J. P. Nagar Third, Phase, Bengaluru - 560 078, Karnataka. India Tel.: +91 80 4657 0300 | Fax: +91 80 4657 0400 | E-mail: info@agnus.in | www.agnus.in | LLPIN: AAB-9882

29th November 2022

10
BSE Limited	National Stock Exchange of India Limited
Phiroze Jeejeebhoy	Exchange Plaza,
Towers, Dalal Street,	Bandra Kurla Complex, Bandra
Mumbai - 400 001	(E), Mumbai - 400051

Scrip code: 541540

Scrip code: SOLARA

Dear Sir/Madam,

Sub: Disclosure under Regulation 10(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 with respect to proposed inter-se transfer of equity shares of Solara Active Pharma Sciences Limited.

Pursuant to Regulation 10(5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 ('SEBI SAST Regulations'), kindly find enclosed herewith disclosure in the prescribed format with respect to proposed inter-se transfer of equity shares of Solara Active Pharma Sciences Limited, among promoter group, through an off-market transaction.

Kindly take the same on record.

Thanking you,

Yours faithfully,

Ramaprasad J S

Designated Partner Devicam Capital LLP DIN: DIN:00173696

Encl.: as above

Copy to: S. Murali Krishna Company Secretary & Compliance Officer Solara Active Pharma Sciences Limited 2nd Floor, Admin Block, 27, Vandaloor, Kelambakkam Road, Keelakottaiyur Village, Melakottaiyur PO Chennai -600127

Regd. Office: Plot No. 30, 'Galaxy', 1st Main Road, J. P. Nagar Third Phase, Bengaluru - 560 078, Karnataka. India Tel.: +91 80 4657 0300 | Fax: +91 80 4657 0400 | E-mail: info@agnus.in | www.agnus.in | LLPIN: AAB-9882

$\bullet$

Format for Disclosures under Regulation 10(5) - Intimation to Stock Exchanges in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

	Name of the Target Company (TC)	Solara Active Pharma Sciences Limited
2.	Name of the acquirer(s)	Devicam Capital LLP
3.		Whether the acquirer(s) is/ are promoters Yes, The Acquirer forms part of the Promoter
	of the TC prior to the transaction. If not, group.
	nature of relationship or association withthe TC or its
	promoters
4.	Details of the proposed acquisition
	a. Name of the person(s) from whom	Karuna Business Solutions LLP
	shares are to be acquired
	b. Proposed date of acquisition	07 December 2022 or thereafter
	Number of shares to be acquired$ C_{\bullet} $	14,00,000 shares
	from each person mentioned in $4(a)$
	above
	d. Total shares to be acquired as $%$ of 3.89%
	share capital of TC
		e. Price at which shares are proposed Rs. 470.25/- (Rupees Four Hundred and Seventy
	to be acquired	and Twenty-Five Paise Only) per share aggregating
		to Rs. 65,83,50,000 / - (Rupees Sixty-Five Crores
		Eighty-Three Lakhs Fifty Thousand Only)
	Rationale, if any, for the proposed	Inter-se transfer of shares amongst the Promoter
	transfer	group
5.	Relevant sub-clause of regulation 10(1)(a) 10(1)(a) (ii) of SEBI SAST Regulationsunder which the acquirer is exempted from
	making open
	offer
6.	If, frequently traded, volume weighted Applicable
	average market price for a period of 60
	trading days preceding the date of issuance	Volume Weighted Average Market Price: Rs. 444.98
	of this notice as traded on the stock	/- (Rupees Four Hundred Forty-Four and Ninety-
	exchange where the maximum volume of	Eight Paise Only)
	trading in the shares of the TC are
	recorded during such period.
	If in-frequently traded, the price as	Not Applicable
	determined in terms of clause (e) of
	sub-regulation (2) of regulation 8.

Regd. Office: Plot No. 30, 'Galaxy', 1st Main Road, J. P. Nagar Third Phase, Bengaluru - 560 078, Karnataka. India Tel.: +91 80 4657 0300 | Fax: +91 80 4657 0400 | E-mail: info@agnus.in | www.agnus.in | LLPIN: AAB-9882

8.	Declaration by the acquirer, that the Applicable-Declaration Attachedacquisition price would not be higher bymore than 25% of the price computed inpoint 6 or point 7 as applicable.
9.	Declaration by the acquirer, that the Applicable-Declaration Attachedtransferor and transferee have complied /will comply with applicable disclosurerequirements in Chapter V of the TakeoverRegulations, 2011 (correspondingprovisions of the repealed TakeoverRegulations 1997)
10.	Declaration by the acquirer that all theconditions specified under regulation$10(1)(a)$ with respect to exemptions hasbeen duly complied with.	Applicable-Declaration Attached
	Shareholding details11.		Before the		After the
			proposedtransaction		proposedtransaction
				$%$ w.r.t	No. of	$\frac{0}{0}$
						w.r.t
				total	shares	total
			shares
			/voting	share	/voting	share
			rights	capital of	rights	capit
				TC		al ofTC
	Acquirer(s) and PACs (other than sellers) $(*)$a
	(i)Devicam Capital LLP		16,53,045	4.59%	30,53,045	8.48%
	Seller (s)b

Signature: Ramaprasad J S Designated Partner Devicam Capital LLP

$\bullet$

Date: 29 November 2022 Place: Bengaluru

Regd. Office: Plot No. 30, 'Galaxy', 1st Main Road, J. P. Nagar Third Phase, Bengaluru - 560 078, Karnataka. India Tel.: +91 80 4657 0300 | Fax : +91 80 4657 0400 | E-mail : info@agnus.in | www.agnus.in | LLPIN : AAB-9882

DECLARATION

November 29, 2022

We, Devicam Capital LLP ("The LLP") hereby declare that the acquisition price Rs. 470.25/- (Rupees Four Hundred and Seventy and Twenty-Five Paise Only) for acquiring 14,00,000 (Fourteen Lakhs) equity shares (through Inter-se Transfer of Shares) of Solara Active Pharma Sciences Limited ("Target Company") by the LLP is not higher by:

"more than 25% of Frequently traded volume weighted average market price for a period of 60 trading days preceding the date of issuance of notice as traded on the stock exchange where maximum volume of trading in the shares of the TC (Target Company) are recorded during such period. - (Point 6 of the Disclosure under Regulation 10 (5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.)"

For Devicam Capital LLP Ramaprasad JS Designated Partner DPIN: 00173696

Regd. Office: Plot No. 30, 'Galaxy', 1st Main Road, J. P. Nagar Third Phase, Bengaluru - 560 078, Karnataka. India Tel.: +91 80 4657 0300 | Fax: +91 80 4657 0400 | E-mail: info@agnus.in | www.agnus.in | LLPIN: AAB-9882

DECLARATION

November 29, 2022

$\bullet$

We, Devicam Capital LLP ("The LLP") hereby declare that:

• Transferor (Karuna Business Solutions LLP) and Transferee (Devicam Capital LLP) have 1. complied/ will comply with applicable disclosure requirements in Chapter V of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.) (Corresponding provisions of repealed Takeover Regulations 1997) (Takeover Regulations, 2011)
• 1. Devicam Capital LLP (The Acquirer) has complied with all the conditions specified under Regulation 10(1)(a) of the Takeover Regulations, 2011 with respect to exemptions has been duly complied with.